Piper Sandler Reiterates Overweight Rating on Inovio Pharmaceuticals, Inc. (INO)
Rating Change Piper Sandler analysts reiterated a Overweight rating on Inovio Pharmaceuticals, Inc. (NASDAQ:INO) on August 03, 2026. Market Context Inovio Pharmaceuticals, Inc.
Read more
